Vanguard Global Advisers »

Immunic shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $35k 32k 1.11

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Immunic

Standard Life Aberdeen
BVF
Avidity Partners Management
Vanguard Capital Management
Vanguard Group
Soleus Capital Management
Laurion Capital Management
Millennium Management
Morgan Stanley
Colony
Nantahala Capital Management
683 Capital Management
Propel Bio Management
Geode Capital Management
Adage Capital Partners GP

View all funds holding Immunic